Allakos Inc reports results for the quarter ended in June - Earnings Summary

Allakos

07/08/2024 22:05

* Allakos Inc  ALLK.OQ  reported a quarterly adjusted loss
of 30
cents​​ per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of -41
cents.  The mean expectation of nine analysts for the quarter
was for a loss of 33 cents per share. Wall Street expected
results to range from -40 cents to -28 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Allakos Inc's reported EPS for the quarter was a loss
of 30
cents​.
    * The company reported a quarterly loss of $26.68 million.
    * Allakos Inc shares had fallen by 21.7% this quarter and
lost 71.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 4.4%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 5
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Allakos Inc is
$2.00 
This summary was machine generated from LSEG data August 7 at
09:05 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.33          -0.30          Beat
 Mar. 31 2024      -0.47          -0.81          Missed
 Dec. 31 2023      -0.47          -0.71          Missed
 Sep. 30 2023      -0.45          -0.52          Missed